# CITALOPRAM HYDROBROMIDE
> **NDA215428** · New Drug Application · Sponsor: ALMATICA · Approved 2022-01-31
## Drug
- **FDA Application Number:** NDA215428
- **Application type:** New Drug Application
- **Brand name:** CITALOPRAM HYDROBROMIDE
- **Generic name:** CITALOPRAM
- **Active ingredients:** CITALOPRAM HYDROBROMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALMATICA
- **Manufacturer:** Almatica Pharma LLC
- **First approval:** 2022-01-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215428)
---
*AI Analytics · CC0 1.0*